ATARA BIOTHERAPEUTICS, INC. Property, Plant and Equipment, Gross
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Property, Plant and Equipment, Gross of $286.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-16
- 2025-12-31: Property, Plant and Equipment, Gross $286.00K.
- 2025-09-30: Property, Plant and Equipment, Gross $551.00K.
- 2025-06-30: Property, Plant and Equipment, Gross $551.00K.
- 2025-03-31: Property, Plant and Equipment, Gross $1.98M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $286.00K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $551.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $551.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.98M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $18.60M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $19.71M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $19.72M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $19.71M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $19.73M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $19.61M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $19.53M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $19.11M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $18.72M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $19.62M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $19.58M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $19.36M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $82.52M 10-K · filed 2023-02-08 | |
| 2021-09-30 | $79.81M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $75.09M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $73.31M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $70.19M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $69.57M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $69.09M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $68.01M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $65.85M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $65.58M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $65.25M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $64.68M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $73.65M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $71.88M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $68.48M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $59.87M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $45.47M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $23.24M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $21.10M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $5.00M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $3.65M 10-K · filed 2018-02-27 | $1.80M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |